Adding of Labels of Statin Dangers
Linkedin

Adding of Labels of Statin Dangers

Los Angeles : CA : USA | Mar 04, 2012 at 1:26 AM PST
XX XX
Views: Pending
 

A class of drugs used to lower down the cholesterol of a person was announced by the Federal regulators to be added with additional warnings to the labels on these statins.

Statins slow down the enzyme that is responsible in the liver’s production of cholesterol. Common brands of these are known with their brand names Crestor, Lipitor and Zocor.

The U.S. Food and Drug and Administration or the FDA, requires that statins must have added warnings in their labels. Warnings should include the risks of liver damage, type 2 diabetes, memory loss and confusion. Statins particularly the lovastatin was found to be contributing to the increasing risk of muscle weakness.

After the decision has made by the agency, it was followed up with an internal meeting between the FDA's Office of Surveillance and Epidemiology and Office of New Drugs.

There is a small anecdotal reports reviewed found especially on the effects of statins on memory loss, according to Dr. Amy Egan, the FDA's deputy director of safety in the division of metabolism drug products. The warning for memory loss of this statins has found to be more serious type of cognitive problems than simple forgetfulness, he added.

Regarding with the new warnings, Egan continued that they cannot establish of causality with statin therapy.

The evaluation of the effects of statins by the division was all just short-term studies and the long-term effects of statin therapy was shown to be unclear. Egan said, to better understand how risky to use the statin at some conditions, it should be determined by the division which statins increase the effects listed in the warnings and what dose contributes to the risk.

But, the experts have pronounced that they had seen effects in some of their patients. Although the need for liver-monitoring test was then removed from the statin labels, many of the experts were still on the concern of the continuing the prescribed tests for their patients.

Dr. Andrew Carroll, a physician at the Renaissance Medical Group in Phoenix, disagree with the notion that they can halt checking for liver function test abnormalities for he said he saw high liver enzymes for around five percent of the patients whom received prescribed statins. This was also made him to recommend the patients to not continue the medication.

However, for many experts, they suggest that patients should not be discouraged of using the statins because of the added warnings in the statin labels. Instead, patients should have to report any side effects to their doctors that they may be experiencing.

Catherine Cooper, a passionate writer and a party goer but hardworking person, likes to unwind and a soak in a hot tub spa is her way of relaxing. The hot tub machine is her favorite amenity at home. It gives her the reason to stay healthy and happy.

Catherine Cooper, a romantic partner and a freelance writer, likes to go bathing in a hot tub. Her friends and her family sometimes join her plunging in a warm soothing hot tub spa in her home.

1 of 1
Long-term use of statins is less risky than thought for patients with a common form of liver disease
Long-term use of statins is less risky than thought for patients with a common form of liver disease
catherinecooper is based in Los Angeles, California, United States of America, and is a Stringer for Allvoices.
Report Credibility
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
 
Advertisement
 

News Stories

 
  • FDA finally admits cholesterol drugs need warning labels about risk for ...

      Natural News
    Nearly 32 million Americans currently take statin drugs to lower their cholesterol levels, but they are probably completely unaware that these drugs can come with side effects like diabetes and memory loss...Because until this week, the FDA didn't...
  • Scripps' warning on statin-induced diabetes

      San Diego Union-Tribune
    Food and Drug Administration has ordered that the labels of cholesterol-lowering drugs -- such as Lipitor and Zocor -- state that the drugs can increase a person's risk of diabetes and memory loss. ( Story ). The subject led to a provocative essay in...
  • FDA Needs New Paradigm; Statins Latest Example

    The FDA is adding new safety warnings to statins about memory loss and diabetes. March 07, 2012 The FDA is adding new safety warnings to statins about memory loss and diabetes. The FDA said Tuesday that it is making changes to the labels of Lipitor (...
  • What Does an Evolving OTC Environment Mean?

      Eye on FDA
    March 5, 2012 Once upon a time, it was quite common for drugs to switch their status from prescription to over-the-counter (OTC) making them much more accessible to people by means of ability to purchase and cost.  Allergy medications and heartburn...
  • Op-Ed Contributor: The Diabetes Dilemma for Statin Users

      The New York Times
    We're overdosing on cholesterol -lowering statins, and the consequence could be a sharp increase in the incidence of Type 2 diabetes . This past week, the Food and Drug Administration raised questions about the side effects of these drugs and...

Blogs

 >

Images

 >
 

More From Allvoices

Report Your News Got a similar story?
Add it to the network!

Or add related content to this report



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.